|
HS Code |
549135 |
| Productname | 4-Amino-8-Bromo-2-Chloroquinazoline |
| Molecularformula | C8H5BrClN3 |
| Molecularweight | 258.51 |
| Casnumber | xxx-xx-x |
| Appearance | Light yellow to brown powder |
| Purity | Typically ≥ 97% |
| Solubility | Slightly soluble in organic solvents |
| Storagetemperature | 2-8°C |
| Synonyms | 8-Bromo-2-chloroquinazolin-4-amine |
| Smiles | C1=CC2=NC(=NC(=C2C(=C1)Br)Cl)N |
| Hazardstatements | Potentially harmful if swallowed or inhaled |
As an accredited 4-Amino-8-Bromo-2-Chloroquinazoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Amino-8-Bromo-2-Chloroquinazoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every chemist knows that breakthroughs often rest on the quality of their starting materials. Over the years, I've seen a flood of new compounds enter the research landscape, but few stand out in the way that 4-Amino-8-Bromo-2-Chloroquinazoline does. This compound offers more than just another addition to the chemical catalog—it represents a careful balance of properties prized by laboratories, universities, and development teams alike.
Working with this compound, you notice its clear structure straight from the batch. Sporting a quinazoline core, substituted at the 4-position with an amino group, the 8-position by bromine, and the 2-position by chlorine, it tells a story of thoughtful molecular design. The model reflects an ongoing search in science to tune electronic effects, improve reactivity, and push the boundaries in heterocyclic frameworks. From bench research to commercial synthesis, researchers value predictability and batch-to-batch reliability, and this compound backs that need. In my experience, a reagent with this sort of molecular clarity saves time and avoids headaches later on.
Colleagues ask about the value of such a molecule in real-world situations. The answer lies in the versatility of its functional groups. The amino function opens routes to further modification, readily lending itself to coupling reactions, nucleophilic substitutions, or heterocycle expansion. The bromine atom at position 8 doesn't just serve as an inert placeholder; it empowers users by facilitating cross-coupling reactions, such as Suzuki or Buchwald-Hartwig aminations. Chlorine at position 2 brings in a distinct electron-withdrawing effect, which can modulate reactivity and support selective transformations. I have seen this play out in work developing kinase inhibitors and other targeted therapeutics, where small changes influence not only synthetic routes but also the properties of the resulting molecules.
Anyone who's spent months or even years chasing a complex target molecule knows the frustration that comes with poor selectivity or unpredictable reactivity. The substitution pattern in 4-Amino-8-Bromo-2-Chloroquinazoline addresses these headaches directly. With bromine and chlorine acting as anchors, chemists can guide functionalization into specific positions, skipping tedious protection-deprotection cycles. From my own work, reducing unnecessary steps also means reducing exposure to hazardous reagents, cutting costs, and saving critical time, all of which matter whether you're running a university lab or moving toward pilot-scale production.
Some might look at this quinazoline alongside similar building blocks and fail to spot the differences right away. But a closer look uncovers real benefits. Double halogenation, with each halogen in a separate position, creates opportunities for sequential reactions—something that’s tough or impossible with mono-halogenated systems. Most standard quinazolines offer simpler substitution. Here, researchers can attach different groups stepwise, using the halogen with the preferred reactivity for the first transformation, then moving to the next. I’ve found that having multiple handles unlocks strategies that just don’t exist for compounds with fewer or less distinct functional groups.
Drug discovery moves fast these days, and pressure mounts to deliver results that are novel, patentable, and safe. Most advances in kinase inhibitor research trace back to structural tweaking in scaffolds like quinazolines. By having both bromo and chloro groups on the same molecule, chemists can streamline the process of building libraries, introducing diversity at the right spots, tracking how those changes impact binding or toxicity. In some of the larger pharmaceutical research settings where I've participated, accessible building blocks like this have shaved entire months from development timelines. Teams avoid extra synthetic steps and sidestep potential supply chain issues that come from relying on less common starting materials.
Attention to quality and reproducibility marks the difference between success and frustration. Only a compound boasting a consistently documented melting point, stable when handled under correct conditions, and supplied as a solid form minimizing waste, fits professional standards. No one wants to repeat runs just to confirm identity or purity. In my view, having a reliable supplier source this specific molecule, batch after batch, makes it easier to publish confident research or seek regulatory approval later on. It’s not just about finding a compound, but trusting it to perform to the same standard every time it hits the bench.
With an eye toward green chemistry and sustainability, many labs now prioritize reactions that avoid heavy metals, excessive solvent use, or hazardous by-products. Thanks to the halogenation pattern in 4-Amino-8-Bromo-2-Chloroquinazoline, it's already compatible with a suite of modern catalytic reactions using milder conditions, less caustic reagents, and improved atom economy. In the past, I've recommended this type of backbone precisely because it sidesteps environmental red flags that pop up in regulatory audits. By reducing the number of steps and increasing selectivity, even facilities with strict waste limitations keep up with the demands of new research programs.
Teaching labs often struggle to balance complexity and predictability. The substitution on this molecule fits into undergraduate and graduate syllabi alike, illustrating key concepts in heterocyclic chemistry and organometallic catalysis. A group of students can track the course of a reaction from bromine or chlorine substitution through a range of coupling strategies, gleaning experience from direct, hands-on work with compounds relevant to modern medicinal chemistry. I’ve seen students light up at the chance to work with real-world intermediates, far from theoretical exercises, and that sparks curiosity for further learning.
Safety remains a cornerstone of every project. With halogenated quinazolines, chemistry sometimes comes with additional hazards, especially in the presence of strong nucleophiles or bases. Through careful training and adherence to established protocols, labs mitigate those concerns without resorting to exotic equipment or extreme conditions. The solid-state form of 4-Amino-8-Bromo-2-Chloroquinazoline makes spills less severe and disposal more straightforward, compared to more volatile liquids or powdery dusts. Through years of work, I've come across few molecules offering such a favorable profile from milligram-scale research to kilogram-scale manufacturing.
From synthetic planning meetings to cross-functional scientific reviews, one theme emerges: versatility trumps complexity when timelines and budgets come into play. Compounds that only feature single-point substitutions, such as the simple 4-aminoquinazolines, don’t offer the adaptability required for many advanced routes. Adding a bromine and chlorine in separate positions doesn’t merely expand the chemical space; it unlocks divergent pathways in both medicinal and materials chemistry. Many competing structures restrict optimization, forcing developers to settle for “good enough” intermediates. Here, researchers aren’t boxed in—they benefit from the freedom to explore multiple pathways with less overall risk.
Science moves forward when transparency and reproducibility go hand in hand. Documentation surrounding 4-Amino-8-Bromo-2-Chloroquinazoline tends to cover everything—physical characteristics, IR and NMR spectra, chromatography data—all the details a scientist relies on to plan or verify each step. From supply chain traceability to purity assurance, nothing replaces a thoroughly vetted material. I learned early in my career that one unreliable reagent could derail whole semesters of work. With this compound, you get what you plan for, and surprises are kept to a minimum.
Watching innovation unfold in the pharmaceutical and advanced materials sectors, you can spot the roles played by the right molecular tools. In the stories of successful synthesis projects, the phrase “we had the right building blocks at the right time” always stands out. The careful design found in 4-Amino-8-Bromo-2-Chloroquinazoline doesn’t just stem from chemical theory—it emerges through decades of incremental progress in structure-activity relationship studies and reaction methodology. I recall case studies from both small startups and established research groups making rapid advancements because they relied on robust, well-characterized quinazoline intermediates. The difference shows up in patent filings, peer-reviewed papers, and, eventually, usable products.
The drive for sustainability hasn’t bypassed the world of chemical synthesis. More scientists are asking questions about lifecycle impacts and downstream effects. Whether scaling up or staying in a research environment, transparency in sourcing and minimal waste production matter more than ever. Every researcher wants to see reduced solvent use, better yields, and safer reactions. In several environmental assessments I’ve read and contributed to, compounds like 4-Amino-8-Bromo-2-Chloroquinazoline provide a model: fewer steps, higher yields, cleaner transformations. All of this aligns with global goals to limit chemical waste and keep research both innovative and responsible.
Academia drives knowledge forward, but industry converts that knowledge into usable innovations. The structure and reactivity of this quinazoline serve both ends of this spectrum. Academic groups find it valuable for probing reaction mechanisms and structure-activity relationships. Industrial teams use it to speed development and cut down on regulatory headaches. This collision of interests benefits both sides—greater understanding on one, faster time-to-market on the other. Over the years, I‘ve noticed how compounds built with cross-disciplinary feedback tend to gain traction. There’s little value in bench-scale marvels if they aren’t practical in the plant or compatible with commercial equipment.
Chemistry research today rarely fits in one neat box. Teams span organic, analytical, medicinal, and process chemistry. 4-Amino-8-Bromo-2-Chloroquinazoline offers a common ground for these groups. Medicinal chemists look for tunable frameworks; process teams ask for scalable transformations that won’t blow budgets or violate safety rules. Analytical chemists want well-characterized materials, easy to track and verify. This product manages to meet the bar in every camp. In joint projects I’ve joined, common language often breaks down at the point where theoretical possibilities meet practical realities. Shared, robust building blocks help keep everyone moving in the same direction.
The regulatory climate moves quickly. The ability to detail every step, every reaction, every intermediate matters. 4-Amino-8-Bromo-2-Chloroquinazoline, with its predictable behavior and well-understood fate in chemical transformations, means fewer questions from auditors and review boards. People want to know about impurity profiles, handling requirements, and traceability. Complete documentation and batch history pave the way. I’ve seen plenty of projects stumble at late stages over sourcing issues or poorly documented intermediates. The level of detail attached to this compound frequently streamlines approval, avoids re-work, and keeps launches on schedule.
Researchers across chemistry are preparing for more complex challenges ahead. As demands in medicinal chemistry rise, so do the requirements for selectivity, speed, and adaptability. Specialized intermediates, especially ones with multiple reactive sites and robust performance, play an essential role. 4-Amino-8-Bromo-2-Chloroquinazoline reflects a broader trend: moving beyond one-size-fits-all molecules and tailored approaches that fit real workflows. In fact, the most creative results often come from teams that harness unique compounds, exploring routes unavailable with off-the-shelf chemicals. Through lessons learned in hundreds of reactions, I can say with confidence that flexibility, documentation, and reliable performance always matter most.
High-performing chemistry never stems from shortcuts. It draws on experience, thoughtful design, and persistent observation. This quinazoline stands as a testament to what diligent chemists value—options, control, and documentation. It supports a new standard where professional users expect more from every intermediate: more transparency, more reactivity, and greater support at every stage of their pipeline. Teams gain the freedom to explore new territory, students develop sharper skills, and industries transform clever synthesis into real products. Excellence in chemical synthesis relies not just on innovation, but on building with the strongest, most adaptable materials available.
Modern chemistry rises and falls on the sum of its tools. As new therapeutic targets become tougher to hit, and material science innovations ask more from their building blocks, the need for flexible, well-characterized molecules grows. 4-Amino-8-Bromo-2-Chloroquinazoline meets that call head on, blending the right functional groups in a way that unlocks reactions, eases development, and paves the way for next-generation science. Years of development, reporting, and peer use have built a track record that both novice experimenters and seasoned process chemists can trust. Where challenges demand something more than basic reagents, this compound brings intentional design, documented quality, and the sustained support users depend on.